• TRM (USD/COP)COP 3,235.59 +1.65% +COP 52.60Colombia's official exchange rate (Financial Superintendence), valid Nov 4 to Nov 4
  • EuroCOP 3,617.08 +1.72% +COP 61.02Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote
  • Mexican pesoCOP 173.98 +3.35% +COP 5.64Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote
Quilla NewsFinance & Technology
ENES

Fresenius Medical Care launches multiFiltratePRO system in the U.S. after FDA clearance

TechnologyInternationalTradingView30 s readAI summary
Image: TradingView

Fresenius Medical Care launched the multiFiltratePRO system in the United States after receiving FDA clearance on October 19, 2026. The clearance includes the Cienby and Calrezdy solutions, which allow regional citrate anticoagulation as indicated. According to the text, this is an initial U.S. commercialization step that expands the company's critical care portfolio, following the recent U.S. introduction of the 5008X.

In 30 seconds

  • Fresenius Medical Care launched the multiFiltratePRO system in the U.S. with FDA clearance dated October 19, 2026.
  • The clearance includes the Cienby and Calrezdy solutions for regional citrate anticoagulation.
  • The company expands its critical care portfolio after the recent U.S. introduction of the 5008X.
Read the full story at TradingView

IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading